HIV‐positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study

• DOI: 10.7448/ias.19.1.20919
• Publication Date: 2016-06-15T16:14:24Z
• Authors: Leila Katirayi; Hazel Namadingo; Mafayo Phiri; Emily A Bobrow; Allan Ahimbisibwe; Aida Yemane Berhan; Nicole Buono; Karen Marie Moland; Thorkild Tylleskär
• Keywords: Regimen

Introduction The implementation of lifelong antiretroviral treatment (ART) for all pregnant women (Option B+) in Malawi has resulted a significant increase the number HIV‐positive initiating treatment. However, research highlighted challenge retaining newly initiated care. This study explores barriers and facilitators that affect woman's decision to initiate adhere Option B+. Methods A total 39 in‐depth interviews 16 focus group discussions were conducted. Eligible ≥18 years old, living with HIV either receiving antenatal care from site or had delivered child within last 18 months, breastfed their received services at one sites. identified by healthcare workers (HCWs) clinic ART unit. Focus groups also conducted HCWs employed these departments. Qualitative data analyzed using Maxqda version 10 (VERBI Software, Berlin, Germany). Results general perception towards drug regimen used B+ was positive; reported fewer side effects acknowledged positive benefits ART. Women felt hopeful about prolonging life having an HIV‐uninfected baby, yet grappled fact is commitment. discussed challenges counselling prevention mother‐to‐child transmission under new guidelines, many struggled on same day as learning status. wanted discuss circumstances husbands first, receive CD4 count obtain test another facility confirm expressed concern might just agree take drugs please them. concerns around loss follow‐up resistance. Conclusions Although significantly increased ART, there are still need be addressed strengthen initiation, adherence retention Strategies upon diagnosis developed improve same‐day initiation long‐term adherence.